Transplantation of neural progenitor cells into the human CNS

研究成果: Short survey査読

1 被引用数 (Scopus)

抄録

The development of regenerative medicine for spinal cord injury (SCI) and intractable diseases of the nervous system using neural progenitor cells (NPCs) has shown great promise, and several clinical trials have begun. In addition, ex vivo gene therapy using genetically engineered NPCs was recently initiated in the clinical setting by Baloh et al., putatively showing enhanced therapeutic effects. Thus, the era of next-generation NPC transplantation therapy is beginning to dawn.

本文言語English
ページ(範囲)897-899
ページ数3
ジャーナルTrends in Molecular Medicine
28
11
DOI
出版ステータスPublished - 2022 11月

ASJC Scopus subject areas

  • 分子医療
  • 分子生物学

フィンガープリント

「Transplantation of neural progenitor cells into the human CNS」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル